EP Patent

EP3402532A4 — INHIBITION OF PROTEIN ASSOCIATED WITH ATAXIA TELANGIECTASIA AND RAD3 (ATR)

Assigned to Jazz Pharmaceuticals Therapeutics Inc · Expires 2019-09-11 · 7y expired

What this patent protects

Patent listed against Camptosar.

Drugs covered by this patent

Patent Metadata

Patent number
EP3402532A4
Jurisdiction
EP
Classification
—
Expires
2019-09-11
Drug substance claim
No
Drug product claim
No
Assignee
Jazz Pharmaceuticals Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.